Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 8/2003

01-12-2003

SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model

Authors: Lesley J. Murray, Tinya J. Abrams, Kelly R. Long, Theresa J. Ngai, Lisa M. Olson, Weiru Hong, Paul K. Keast, Jacqueline A. Brassard, Anne Marie O'Farrell, Julie M. Cherrington, Nancy K. Pryer

Published in: Clinical & Experimental Metastasis | Issue 8/2003

Login to get access
Metadata
Title
SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model
Authors
Lesley J. Murray
Tinya J. Abrams
Kelly R. Long
Theresa J. Ngai
Lisa M. Olson
Weiru Hong
Paul K. Keast
Jacqueline A. Brassard
Anne Marie O'Farrell
Julie M. Cherrington
Nancy K. Pryer
Publication date
01-12-2003
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 8/2003
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/B:CLIN.0000006873.65590.68

Other articles of this Issue 8/2003

Clinical & Experimental Metastasis 8/2003 Go to the issue

OriginalPaper

Melanoma invasion in reconstructed human skin is influenced by skin cells – investigation of the role of proteolytic enzymes

OriginalPaper

Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis

OriginalPaper

Acknowledgements

OriginalPaper

Author Index to Volume 20

OriginalPaper

Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype

OriginalPaper

S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits